Márcia Cristina Ferreira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Márcia Cristina Ferreira has a total of 123 co-authors. Here are the top co-authors by number of shared publications:
- Márcia Mendonça Carneiro
Department of Obstetrics and Gynecology, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil
14 shared publications - Fernando Marcos dos Reis
Department of Obstetrics and Gynecology Universidade Federal de Minas Gerais Belo Horizonte Brazil
13 shared publications - Ana Luiza Lunardi Rocha
Federal University of Minas Gerais Belo Horizonte Brazil
5 shared publications - Felice Petraglia
Obstetrics and Gynaecology Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50134 Florence, Italy
5 shared publications Rívia Mara Lamaita
Department of Obstetrics and Gynecology, Federal University of Minas Gerais, Belo Horizonte - Brazil
5 shared publications- Agnaldo Lopes da Silva Filho
Universidade Federal de Minas Gerais Belo Horizonte MG Brazil Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
3 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by Editora Ilustracao in Revista Ilustração
- Vol. 7 (7) , 329-359
HUMANIZAÇÃO DO CUIDADO EM SERVIÇOS DE SAÚDE: UMA REVISÃO INTEGRATIVA DAS DIMENSÕES ÉTICA, EMOCIONAL E ORGANIZACIONAL DA PRÁTICA MULTIPROFISSIONAL
Analisar as evidências científicas acerca das dimensões ética, emocional e organizacional que permeiam a humanização do cuidado em serviços de saúde, identificando seus principais desafios, potencialidades e implicações para a prática multiprofissional e para a gestão dos sistemas de saúde. Realizou-se uma revisão integrativa da literatura, conduzida conforme as etapas propostas por Mendes, Silveira e Galvão e orientada pelas recomendações do PRISMA 2020 para transparência do processo de seleção dos estudos. As buscas foram realizadas nas bases SciELO, PubMed/MEDLINE e Google Scholar, utilizando descritores controlados e palavras-chave relacionadas à humanização do cuidado, Política Nacional de Humanização, equipe multiprofissional e serviços de saúde, combinados por operadores booleanos. Foram incluídos estudos publicados entre 2022 e 2025, disponíveis na íntegra, em português e inglês, que abordassem a temática sob perspectivas ética, emocional e/ou organizacional. Os 94 estudos selecionados foram submetidos à leitura integral, extração padronizada dos dados e síntese temática. As evidências demonstram que a humanização do cuidado constitui um processo multidimensional que transcende práticas de acolhimento e cordialidade, envolvendo a valorização da autonomia do paciente, a comunicação qualificada, o fortalecimento do vínculo terapêutico, o suporte emocional aos usuários e profissionais e a organização dos processos de trabalho. Foram identificados como principais obstáculos a sobrecarga laboral, a insuficiência de recursos humanos e materiais, a fragmentação da assistência, a precarização das relações de trabalho e as limitações na formação humanística dos profissionais. Em contrapartida, destacaram-se como fatores promotores da humanização a atuação colaborativa das equipes multiprofissionais, a gestão participativa, a educação permanente em saúde, o fortalecimento da Atenção Primária à Saúde e a implementação efetiva das diretrizes da Política Nacional de Humanização. A humanização do cuidado configura-se como estratégia essencial para a qualificação da assistência, para o fortalecimento da integralidade do cuidado e para a sustentabilidade dos sistemas de saúde. Sua efetivação requer mudanças estruturais, organizacionais e formativas, articulando políticas públicas, gestão institucional e desenvolvimento de competências éticas, relacionais e interprofissionais. Os resultados oferecem subsídios para o aprimoramento das práticas assistenciais, da gestão em saúde e da formulação de políticas voltadas à consolidação de uma cultura organizacional centrada na pessoa e orientada pelos princípios do Sistema Único de Saúde.
- 1 July 2026
- Published by Editora Ilustracao in Revista Ilustração
- Vol. 7 (7) , 329-359
Open AccessHUMANIZAÇÃO DO CUIDADO EM SERVIÇOS DE SAÚDE: UMA REVISÃO INTEGRATIVA DAS DIMENSÕES ÉTICA, EMOCIONAL E ORGANIZACIONAL DA PRÁTICA MULTIPROFISSIONAL
Analisar as evidências científicas acerca das dimensões ética, emocional e organizacional que permeiam a humanização do cuidado em serviços de saúde, identificando seus principais desafios, potencialidades e implicações para a prática multiprofissional e para a gestão dos sistemas de saúde. Realizou-se uma revisão integrativa da literatura, conduzida conforme as etapas propostas por Mendes, Silveira e Galvão e orientada pelas recomendações do PRISMA 2020 para transparência do processo de seleção dos estudos. As buscas foram realizadas nas bases SciELO, PubMed/MEDLINE e Google Scholar, utilizando descritores controlados e palavras-chave relacionadas à humanização do cuidado, Política Nacional de Humanização, equipe multiprofissional e serviços de saúde, combinados por operadores booleanos. Foram incluídos estudos publicados entre 2022 e 2025, disponíveis na íntegra, em português e inglês, que abordassem a temática sob perspectivas ética, emocional e/ou organizacional. Os 94 estudos selecionados foram submetidos à leitura integral, extração padronizada dos dados e síntese temática. As evidências demonstram que a humanização do cuidado constitui um processo multidimensional que transcende práticas de acolhimento e cordialidade, envolvendo a valorização da autonomia do paciente, a comunicação qualificada, o fortalecimento do vínculo terapêutico, o suporte emocional aos usuários e profissionais e a organização dos processos de trabalho. Foram identificados como principais obstáculos a sobrecarga laboral, a insuficiência de recursos humanos e materiais, a fragmentação da assistência, a precarização das relações de trabalho e as limitações na formação humanística dos profissionais. Em contrapartida, destacaram-se como fatores promotores da humanização a atuação colaborativa das equipes multiprofissionais, a gestão participativa, a educação permanente em saúde, o fortalecimento da Atenção Primária à Saúde e a implementação efetiva das diretrizes da Política Nacional de Humanização. A humanização do cuidado configura-se como estratégia essencial para a qualificação da assistência, para o fortalecimento da integralidade do cuidado e para a sustentabilidade dos sistemas de saúde. Sua efetivação requer mudanças estruturais, organizacionais e formativas, articulando políticas públicas, gestão institucional e desenvolvimento de competências éticas, relacionais e interprofissionais. Os resultados oferecem subsídios para o aprimoramento das práticas assistenciais, da gestão em saúde e da formulação de políticas voltadas à consolidação de uma cultura organizacional centrada na pessoa e orientada pelos princípios do Sistema Único de Saúde.
- Open Access
- 9 June 2026
- Published by Unified Journals Network Publishing House in Revista Saúde dos Vales
- Vol. 8 (05) , 1-45
ACREDITAÇÃO NA GESTÃO EM SAÚDE HOSPITALAR: ATENDIMENTO DAS NECESSIDADES DE SAÚDE DOS USUÁRIOS
A acreditação hospitalar tem se consolidado como um importante instrumento de governança institucional voltado à qualificação dos serviços de saúde, à segurança do paciente e ao fortalecimento dos mecanismos de gestão orientados por evidências. Apesar da crescente adoção de modelos de certificação da qualidade no contexto hospitalar, persistem lacunas quanto à compreensão de sua efetiva contribuição para o atendimento das necessidades de saúde dos usuários, especialmente sob a perspectiva do direito à saúde e da gestão centrada na pessoa. Nesse contexto, o presente estudo objetiva analisar as contribuições da acreditação na gestão em saúde hospitalar para o atendimento das necessidades de saúde dos usuários. Trata-se de uma pesquisa de natureza qualitativa, desenvolvida por meio de revisão integrativa da literatura, com levantamento realizado nas bases SciELO, LILACS, Biblioteca Virtual em Saúde (BVS) e Google Scholar, contemplando produções científicas publicadas entre 2013 e 2026. Os resultados evidenciam que a acreditação promove a padronização dos processos assistenciais e gerenciais, fortalece a cultura organizacional da qualidade, amplia a utilização de indicadores de desempenho, estimula a adoção de protocolos clínicos e administrativos e favorece a melhoria contínua dos serviços. Observou-se, ainda, que instituições acreditadas apresentam maior capacidade de organizar fluxos assistenciais, reduzir riscos, qualificar a tomada de decisão e responder de forma mais efetiva às necessidades de saúde relacionadas ao acesso, à integralidade do cuidado, à segurança do paciente e à satisfação dos usuários. Conclui-se que a acreditação constitui relevante mecanismo de governança hospitalar, contribuindo para a efetivação do direito fundamental à saúde mediante a promoção de práticas gerenciais orientadas pela qualidade, eficiência, transparência e sustentabilidade institucional.
- 9 June 2026
- Published by Unified Journals Network Publishing House in Revista Saúde dos Vales
- Vol. 8 (05) , 1-45
Open AccessACREDITAÇÃO NA GESTÃO EM SAÚDE HOSPITALAR: ATENDIMENTO DAS NECESSIDADES DE SAÚDE DOS USUÁRIOS
A acreditação hospitalar tem se consolidado como um importante instrumento de governança institucional voltado à qualificação dos serviços de saúde, à segurança do paciente e ao fortalecimento dos mecanismos de gestão orientados por evidências. Apesar da crescente adoção de modelos de certificação da qualidade no contexto hospitalar, persistem lacunas quanto à compreensão de sua efetiva contribuição para o atendimento das necessidades de saúde dos usuários, especialmente sob a perspectiva do direito à saúde e da gestão centrada na pessoa. Nesse contexto, o presente estudo objetiva analisar as contribuições da acreditação na gestão em saúde hospitalar para o atendimento das necessidades de saúde dos usuários. Trata-se de uma pesquisa de natureza qualitativa, desenvolvida por meio de revisão integrativa da literatura, com levantamento realizado nas bases SciELO, LILACS, Biblioteca Virtual em Saúde (BVS) e Google Scholar, contemplando produções científicas publicadas entre 2013 e 2026. Os resultados evidenciam que a acreditação promove a padronização dos processos assistenciais e gerenciais, fortalece a cultura organizacional da qualidade, amplia a utilização de indicadores de desempenho, estimula a adoção de protocolos clínicos e administrativos e favorece a melhoria contínua dos serviços. Observou-se, ainda, que instituições acreditadas apresentam maior capacidade de organizar fluxos assistenciais, reduzir riscos, qualificar a tomada de decisão e responder de forma mais efetiva às necessidades de saúde relacionadas ao acesso, à integralidade do cuidado, à segurança do paciente e à satisfação dos usuários. Conclui-se que a acreditação constitui relevante mecanismo de governança hospitalar, contribuindo para a efetivação do direito fundamental à saúde mediante a promoção de práticas gerenciais orientadas pela qualidade, eficiência, transparência e sustentabilidade institucional.
- Open Access
- 29 October 2025
- Published by Federação das Associações de Ginecologia e Obstetrícia in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 47
Use of oral neuromodulators in chronic pelvic painNumber 8 – 2025
Key points •Chronic pelvic pain is a common and complex condition that significantly affects women’s quality of life. •Neuropathic pain and nociplastic pain are important components in the pain picture of these patients and should be considered in clinical treatment. •Oral neuromodulators, antidepressants and anticonvulsants for the control of neuropathic and nociplastic pain should be […] Key points •Chronic pelvic pain is a common and complex condition that significantly affects women’s quality of life. •Neuropathic pain and nociplastic pain are important components in the pain picture of these patients and should be considered in clinical treatment. •Oral neuromodulators, antidepressants and anticonvulsants for the control of neuropathic and nociplastic pain should be […]
- 29 October 2025
- Published by Federação das Associações de Ginecologia e Obstetrícia in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 47
Open AccessUse of oral neuromodulators in chronic pelvic painNumber 8 – 2025
Key points •Chronic pelvic pain is a common and complex condition that significantly affects women’s quality of life. •Neuropathic pain and nociplastic pain are important components in the pain picture of these patients and should be considered in clinical treatment. •Oral neuromodulators, antidepressants and anticonvulsants for the control of neuropathic and nociplastic pain should be […] Key points •Chronic pelvic pain is a common and complex condition that significantly affects women’s quality of life. •Neuropathic pain and nociplastic pain are important components in the pain picture of these patients and should be considered in clinical treatment. •Oral neuromodulators, antidepressants and anticonvulsants for the control of neuropathic and nociplastic pain should be […]
- 1 December 2021
- Published by Taylor & Francis in Women & Health
- Vol. 62 (1) , 3-11
Endometriosis fertility index predicts pregnancy in women operated on for moderate and severe symptomatic endometriosis
Endometriosis Fertility Index (EFI) is a clinical staging system created to predict spontaneous pregnancy outcomes in patients with endometriosis. The present study aimed at evaluating the performance of EFI in symptomatic patients, submitted to laparoscopy for moderate and severe endometriosis associated to infertility in a Brazilian population. Seventy-seven women with endometriosis and pelvic pain, who desired to become pregnant, were selected from a tertiary care unit between those operated on between May 2007 and March 2017. All of them were submitted to laparoscopy for the surgical treatment of endometriosis and allowed to attempt natural conception for 36 months or immediately referred to in vitro fertilization (IVF). EFI was calculated according to surgical description and clinical information in medical records. Pregnancy rates and live birth rates after natural conception or IVF are reported and correlated to EFI. Fifty-three women tried natural conception and 24 were referred to IVF. Of the 53 who tried natural conception, 29 achieved pregnancy (54.7%) and 28 had live birth (52.8%). The majority of pregnancies (82.7%) occurred in the first 12 months after surgery and 75% of the patients who became spontaneously pregnant had EFI ≥ 7. Of the 24 patients referred to IVF, 13 became pregnant (54.1%) and 10 had live birth (41.7%). Infertility duration of 36 months or more and the presence of endometrioma increased the probability of having EFI ≤ 5. The overall live birth rate (LBR) for patients with low EFI scores (2–4) was 17% compared with 83.8% for those with higher EFI scores (6–9). EFI predicts pregnancy rates in patients operated on for moderate and severe endometriosis. Scores seem also to predict pregnancy rates after IVF.
- 1 December 2021
- Published by Taylor & Francis in Women & Health
- Vol. 62 (1) , 3-11
Endometriosis fertility index predicts pregnancy in women operated on for moderate and severe symptomatic endometriosis
Endometriosis Fertility Index (EFI) is a clinical staging system created to predict spontaneous pregnancy outcomes in patients with endometriosis. The present study aimed at evaluating the performance of EFI in symptomatic patients, submitted to laparoscopy for moderate and severe endometriosis associated to infertility in a Brazilian population. Seventy-seven women with endometriosis and pelvic pain, who desired to become pregnant, were selected from a tertiary care unit between those operated on between May 2007 and March 2017. All of them were submitted to laparoscopy for the surgical treatment of endometriosis and allowed to attempt natural conception for 36 months or immediately referred to in vitro fertilization (IVF). EFI was calculated according to surgical description and clinical information in medical records. Pregnancy rates and live birth rates after natural conception or IVF are reported and correlated to EFI. Fifty-three women tried natural conception and 24 were referred to IVF. Of the 53 who tried natural conception, 29 achieved pregnancy (54.7%) and 28 had live birth (52.8%). The majority of pregnancies (82.7%) occurred in the first 12 months after surgery and 75% of the patients who became spontaneously pregnant had EFI ≥ 7. Of the 24 patients referred to IVF, 13 became pregnant (54.1%) and 10 had live birth (41.7%). Infertility duration of 36 months or more and the presence of endometrioma increased the probability of having EFI ≤ 5. The overall live birth rate (LBR) for patients with low EFI scores (2–4) was 17% compared with 83.8% for those with higher EFI scores (6–9). EFI predicts pregnancy rates in patients operated on for moderate and severe endometriosis. Scores seem also to predict pregnancy rates after IVF.
- 1 February 2021
- Published by Elsevier in Acta Histochemica
- Vol. 123 (2) , 151670
Pro-caspase-3 is constitutively expressed in luteinized granulosa cells from women undergoing controlled ovarian stimulation for in vitro fertilization
- 1 February 2021
- Published by Elsevier in Acta Histochemica
- Vol. 123 (2) , 151670
Pro-caspase-3 is constitutively expressed in luteinized granulosa cells from women undergoing controlled ovarian stimulation for in vitro fertilization
- 16 August 2018
- Published by Wiley in Cell Biology International
- Vol. 42 (10) , 1276-1281
Clinical correlation of apoptosis in human granulosa cells—A review
The quality of oocytes depends on interactions with surrounding granulosa cells. Granulosa cells are essential in normal follicular maturation process since they produce steroidal hormones and growth factors, and they play a crucial role in follicular atresia. The success in reproductive biology and medicine depends on reliable assessment of oocyte and embryo viability which presently mainly bases on oocyte and embryo morphology. Recent investigations have tried to establish an evaluation system for oocyte quality and to predict outcome of in vitro fertilization (IVF) based on the incidence of granulosa cells and cumulus cells apoptosis. Apoptosis of granulosa cells seems to have a negative effect on conception and pregnancy rates in IFV programs. Thus, in this review we present a brief outline of clinical correlation of apoptosis in human granulosa cells and cumulus cells, and its influence upon oocyte quality and IFV outcome. Taken together, understanding the influence of granulosa cell apoptosis on oocyte quality and maturity as well as on embryo health may ultimately allow scientists and clinicians to harness better protocols of ovarian stimulation for infertility treatments.
- 16 August 2018
- Published by Wiley in Cell Biology International
- Vol. 42 (10) , 1276-1281
Clinical correlation of apoptosis in human granulosa cells—A review
The quality of oocytes depends on interactions with surrounding granulosa cells. Granulosa cells are essential in normal follicular maturation process since they produce steroidal hormones and growth factors, and they play a crucial role in follicular atresia. The success in reproductive biology and medicine depends on reliable assessment of oocyte and embryo viability which presently mainly bases on oocyte and embryo morphology. Recent investigations have tried to establish an evaluation system for oocyte quality and to predict outcome of in vitro fertilization (IVF) based on the incidence of granulosa cells and cumulus cells apoptosis. Apoptosis of granulosa cells seems to have a negative effect on conception and pregnancy rates in IFV programs. Thus, in this review we present a brief outline of clinical correlation of apoptosis in human granulosa cells and cumulus cells, and its influence upon oocyte quality and IFV outcome. Taken together, understanding the influence of granulosa cell apoptosis on oocyte quality and maturity as well as on embryo health may ultimately allow scientists and clinicians to harness better protocols of ovarian stimulation for infertility treatments.
- 1 January 2018
- Published by Springer Nature in Reproductive Sciences
- Vol. 25 (1) , 19-25
18F-Fluorocholine Uptake and Positron Emission Tomography Imaging in Rat Peritoneal Endometriosis
Endometriosis is a debilitating disease that still needs surgery to be confirmed. Endometriosis is associated with increased plasma levels of phosphatidylcholines. 18F-fluorocholine ([18F]FCH) is a radiopharmaceutical that is metabolized to phosphatidylcholine inside the cells and can be traced by positron emission tomography (PET). Here we evaluate [18F]FCH as a potential tool for the noninvasive diagnosis of peritoneal endometriosis. Adult female Wistar rats had autologous uterine fragments dissected and grafted to the peritoneal wall to model peritoneal endometriosis. Ex vivo biodistribution assay and PET imaging studies were performed 30 minutes after [18F]FCH administration. The [18F]FCH uptake was 3-fold higher in endometriotic implant tissues than in muscle or peritoneum. Positron emission tomography imaging revealed the grafted uterine tissue in contrast to surrounding structures. Region-of-interest analysis of the reconstructed images showed higher accumulation of [18F]FCH by endometriotic lesions, 0.34 (0.04)% of injected dose per gram of tissue (ID/g), in comparison with muscle tissue, 0.08 (0.01)% ID/g. However, sham implants with fat tissue were also detectable in PET imaging. These preliminary findings of [18F]FCH uptake by ectopic uterine tissue implants and their localization by PET imaging encourage the future evaluation of this technique to detect small superficial endometriosis lesions in humans. Study protocols need to be further perfected and adapted for tests in women with endometriosis.
- 1 January 2018
- Published by Springer Nature in Reproductive Sciences
- Vol. 25 (1) , 19-25
18F-Fluorocholine Uptake and Positron Emission Tomography Imaging in Rat Peritoneal Endometriosis
Endometriosis is a debilitating disease that still needs surgery to be confirmed. Endometriosis is associated with increased plasma levels of phosphatidylcholines. 18F-fluorocholine ([18F]FCH) is a radiopharmaceutical that is metabolized to phosphatidylcholine inside the cells and can be traced by positron emission tomography (PET). Here we evaluate [18F]FCH as a potential tool for the noninvasive diagnosis of peritoneal endometriosis. Adult female Wistar rats had autologous uterine fragments dissected and grafted to the peritoneal wall to model peritoneal endometriosis. Ex vivo biodistribution assay and PET imaging studies were performed 30 minutes after [18F]FCH administration. The [18F]FCH uptake was 3-fold higher in endometriotic implant tissues than in muscle or peritoneum. Positron emission tomography imaging revealed the grafted uterine tissue in contrast to surrounding structures. Region-of-interest analysis of the reconstructed images showed higher accumulation of [18F]FCH by endometriotic lesions, 0.34 (0.04)% of injected dose per gram of tissue (ID/g), in comparison with muscle tissue, 0.08 (0.01)% ID/g. However, sham implants with fat tissue were also detectable in PET imaging. These preliminary findings of [18F]FCH uptake by ectopic uterine tissue implants and their localization by PET imaging encourage the future evaluation of this technique to detect small superficial endometriosis lesions in humans. Study protocols need to be further perfected and adapted for tests in women with endometriosis.
- Open Access
- 1 January 2018
- Published by GN1 Sistemas e Publicacoes Ltd. in JBRA Assisted Reproduction
- Vol. 22 (3) , 244-252
Motherhood after breast cancer: can we balance fertility preservation and cancer treatment? A narrative review of the literature
Breast cancer may affect young women who have not yet completed childbearing. Assisted reproductive technology (ART) provides alternatives for fertility preservation such as oocyte, embryo or ovarian tissue cryopreservation. We reviewed the published literature on fertility-preserving management in breast cancer, aiming at finding evidence to answer the following questions: (1) What are the fertility sparing options available?; (2) How do these women respond to IVF? and (3) Can pregnancy influence breast cancer recurrence? There is a paucity of publications describing clinical experience and outcome data which limits accessibility to fertility preservation in this setting. Presently, oocyte or embryo cryopreservation are the main options for fertility preservation. IVF success rates are comparable to the ones of non-oncological populations according to the woman's age but current published studies lack data on definitive success rates following embryo banking for cancer patients. The perception that IVF and pregnancy may worsen cancer prognosis remains, despite the lack of scientific evidence to support this notion. Published studies show reassuring results for pregnancies occurring > 2 years after breast cancer diagnosis. The best published evidence suggests pregnancy after breast cancer does not increase the risk of disease recurrence, thus pregnancy should not be forbidden once treatment is completed. Decision making for women diagnosed with cancer requires up-to-date knowledge of the efficacy and safety of available options. Providing consultation with a reproductive specialist and appropriate information on fertility preservation for these women should be an essential aspect of their supportive care.
- 1 January 2018
- Published by GN1 Sistemas e Publicacoes Ltd. in JBRA Assisted Reproduction
- Vol. 22 (3) , 244-252
Open AccessMotherhood after breast cancer: can we balance fertility preservation and cancer treatment? A narrative review of the literature
Breast cancer may affect young women who have not yet completed childbearing. Assisted reproductive technology (ART) provides alternatives for fertility preservation such as oocyte, embryo or ovarian tissue cryopreservation. We reviewed the published literature on fertility-preserving management in breast cancer, aiming at finding evidence to answer the following questions: (1) What are the fertility sparing options available?; (2) How do these women respond to IVF? and (3) Can pregnancy influence breast cancer recurrence? There is a paucity of publications describing clinical experience and outcome data which limits accessibility to fertility preservation in this setting. Presently, oocyte or embryo cryopreservation are the main options for fertility preservation. IVF success rates are comparable to the ones of non-oncological populations according to the woman's age but current published studies lack data on definitive success rates following embryo banking for cancer patients. The perception that IVF and pregnancy may worsen cancer prognosis remains, despite the lack of scientific evidence to support this notion. Published studies show reassuring results for pregnancies occurring > 2 years after breast cancer diagnosis. The best published evidence suggests pregnancy after breast cancer does not increase the risk of disease recurrence, thus pregnancy should not be forbidden once treatment is completed. Decision making for women diagnosed with cancer requires up-to-date knowledge of the efficacy and safety of available options. Providing consultation with a reproductive specialist and appropriate information on fertility preservation for these women should be an essential aspect of their supportive care.
- 25 October 2017
- Published by SAGE Publications in Journal of Endometriosis and Pelvic Pain Disorders
- Vol. 9 (4) , 275-278
Tumor Necrosis Factor and its Soluble Receptors as Potential Diagnostic Markers of Endometriosis
Introduction: Tumor necrosis factor (TNF) is a proinflammatory and angiogenic factor produced by activated macrophages. TNF acts through the cell membrane receptors TNFR1 and TNFR2, whose soluble forms play an important role in regulating TNF activity through competition with its receptors. The aim of this study was to evaluate whether TNF and/or its soluble receptors are useful to detect endometriosis in women undergoing laparoscopy for gynecological complains. Methods: This was a prospective, controlled, cross-sectional study including 75 consecutive women scheduled for gynecological laparoscopy due to chronic pelvic pain, infertility, or a pelvic image suggestive of endometrioma. Plasma TNF and soluble TNF receptors (sTNFR1 and sTNFR2) were measured by flow cytometry with the Cytometric Bead Array Human TH1/TH2 Kit (BD Biosciences). Results: Women ultimately proven to have endometriosis had lower preoperative plasma levels of sTNFR1 (median 81 pg/mL vs. 121 pg/mL, p<0.05), resulting in higher TNF/sTNFR1 ratios compared to those without endometriosis (0.055 vs. 0.033, p<0.05). Using the cut-off <108 pg/mL for plasma sTNFR1 to detect endometriosis in this setting, the sensitivity was 51.6% (95% confidence interval [CI], 35%-68%), the specificity was 75.0% (95% CI, 61%-85%) and the positive likelihood ratio was 2.1 (95% CI, 1.1-3.8). The area under the ROC curve was 0.647 (SE = 0.065; 95% CI, 0.519-0.774; p = 0.031). Conclusions: Plasma sTNFR1 levels are lower in symptomatic women with confirmed endometriosis compared to symptomatic women without endometriosis. The lower plasma sTNFR1 levels may increase the bioavailability of TNF, thereby contributing to the systemic low grade inflammation associated with endometriosis.
- 25 October 2017
- Published by SAGE Publications in Journal of Endometriosis and Pelvic Pain Disorders
- Vol. 9 (4) , 275-278
Tumor Necrosis Factor and its Soluble Receptors as Potential Diagnostic Markers of Endometriosis
Introduction: Tumor necrosis factor (TNF) is a proinflammatory and angiogenic factor produced by activated macrophages. TNF acts through the cell membrane receptors TNFR1 and TNFR2, whose soluble forms play an important role in regulating TNF activity through competition with its receptors. The aim of this study was to evaluate whether TNF and/or its soluble receptors are useful to detect endometriosis in women undergoing laparoscopy for gynecological complains. Methods: This was a prospective, controlled, cross-sectional study including 75 consecutive women scheduled for gynecological laparoscopy due to chronic pelvic pain, infertility, or a pelvic image suggestive of endometrioma. Plasma TNF and soluble TNF receptors (sTNFR1 and sTNFR2) were measured by flow cytometry with the Cytometric Bead Array Human TH1/TH2 Kit (BD Biosciences). Results: Women ultimately proven to have endometriosis had lower preoperative plasma levels of sTNFR1 (median 81 pg/mL vs. 121 pg/mL, p<0.05), resulting in higher TNF/sTNFR1 ratios compared to those without endometriosis (0.055 vs. 0.033, p<0.05). Using the cut-off <108 pg/mL for plasma sTNFR1 to detect endometriosis in this setting, the sensitivity was 51.6% (95% confidence interval [CI], 35%-68%), the specificity was 75.0% (95% CI, 61%-85%) and the positive likelihood ratio was 2.1 (95% CI, 1.1-3.8). The area under the ROC curve was 0.647 (SE = 0.065; 95% CI, 0.519-0.774; p = 0.031). Conclusions: Plasma sTNFR1 levels are lower in symptomatic women with confirmed endometriosis compared to symptomatic women without endometriosis. The lower plasma sTNFR1 levels may increase the bioavailability of TNF, thereby contributing to the systemic low grade inflammation associated with endometriosis.
- 1 May 2017
- Published by Springer Nature in Reproductive Sciences
- Vol. 24 (5) , 720-725
Implantation Failure Is Associated With Increased α-Inhibin and β-Glycan Gene Expression in Secretory Phase Endometrium: Nested Case-Control Study of Infertile Women Undergoing IVF/Fresh Embryo Transfer
Embryo implantation involves a complex sequence of events, and a large amount of molecules have been postulated to be involved in the interaction of embryo and endometrium. This study evaluated the endometrial expression of α-inhibin and β-glycan in the mid-secretory phase of women scheduled to in vitro fertilization (IVF) and tested whether these markers are associated with implantation failure. We performed a nested case–control study including 52 women submitted to IVF and embryo transfer, divided into 2 groups: cases with implantation failure (n = 33) and controls with confirmed clinical pregnancy (n = 19). Endometrial α-inhibin and β-glycan gene expression was evaluated in the mid-secretory phase of the natural menstrual cycle immediately before IVF, using real-time polymerase chain reaction. We found a higher gene expression of α-inhibin (fold increase = 2.14 ± 0.32, P < .05) and β-glycan (fold increase = 1.44 ± 0.16, P < .05) in implantation failure patients compared to confirmed clinical pregnancy patients. The areas under the receiver operating characteristics curves for prediction of implantation failure in this context were 0.692 and 0.678 for α-inhibin and β-glycan, respectively. The present results suggest that high expression levels of α-inhibin and β-glycan transcripts in secretory phase endometrium are associated with a lower chance of achieving pregnancy with IVF.
- 1 May 2017
- Published by Springer Nature in Reproductive Sciences
- Vol. 24 (5) , 720-725
Implantation Failure Is Associated With Increased α-Inhibin and β-Glycan Gene Expression in Secretory Phase Endometrium: Nested Case-Control Study of Infertile Women Undergoing IVF/Fresh Embryo Transfer
Embryo implantation involves a complex sequence of events, and a large amount of molecules have been postulated to be involved in the interaction of embryo and endometrium. This study evaluated the endometrial expression of α-inhibin and β-glycan in the mid-secretory phase of women scheduled to in vitro fertilization (IVF) and tested whether these markers are associated with implantation failure. We performed a nested case–control study including 52 women submitted to IVF and embryo transfer, divided into 2 groups: cases with implantation failure (n = 33) and controls with confirmed clinical pregnancy (n = 19). Endometrial α-inhibin and β-glycan gene expression was evaluated in the mid-secretory phase of the natural menstrual cycle immediately before IVF, using real-time polymerase chain reaction. We found a higher gene expression of α-inhibin (fold increase = 2.14 ± 0.32, P < .05) and β-glycan (fold increase = 1.44 ± 0.16, P < .05) in implantation failure patients compared to confirmed clinical pregnancy patients. The areas under the receiver operating characteristics curves for prediction of implantation failure in this context were 0.692 and 0.678 for α-inhibin and β-glycan, respectively. The present results suggest that high expression levels of α-inhibin and β-glycan transcripts in secretory phase endometrium are associated with a lower chance of achieving pregnancy with IVF.